Revolution Medicines, Inc. - Common Stock (RVMD)
CUSIP: 76155X100
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 192,966,469
- Total 13F shares
- 190,726,235
- Share change
- -183,823
- Total reported value
- $7,017,009,498
- Put/Call ratio
- 80%
- Price per share
- $36.79
- Number of holders
- 305
- Value change
- -$4,134,347
- Number of buys
- 168
- Number of sells
- 123
Quarterly Holders Quick Answers
What is CUSIP 76155X100?
CUSIP 76155X100 identifies RVMD - Revolution Medicines, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 76155X100:
Top shareholders of RVMD - Revolution Medicines, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
8.6%
|
16,612,035
|
$587,401,558 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
4.5%
from 13D/G
|
14,692,392
|
$519,522,981 | — | 31 Mar 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
—
mixed-class rows
|
13,654,777
mixed-class rows
|
$478,591,272 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6.1%
|
11,787,921
|
$416,820,887 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
5.3%
|
10,190,071
|
$380,566,792 | — | 31 Mar 2025 | |
| Thilo Schroeder |
3/4/5
|
Director |
—
class O/S missing
|
7,601,087
|
$349,650,002 | — | 05 Dec 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
4.1%
|
7,936,972
|
$280,651,330 | — | 31 Mar 2025 | |
| Nextech Invest, Ltd. |
13F
|
Company |
3.9%
|
7,601,087
|
$268,774,436 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
3.9%
|
7,535,771
|
$266,464,864 | — | 31 Mar 2025 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
3.2%
|
6,178,111
|
$218,458,005 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
3%
|
5,804,919
|
$205,261,936 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
—
mixed-class rows
|
6,198,943
mixed-class rows
|
$198,027,000 | — | 31 Mar 2025 | |
| BVF INC/IL |
13F
|
Company |
2.6%
|
4,982,384
|
$176,177,098 | — | 31 Mar 2025 | |
| Bellevue Group AG |
13F
|
Company |
2.3%
|
4,374,300
|
$154,675,248 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
4,142,414
|
$146,510,339 | — | 31 Mar 2025 | |
| Alphabet Inc. |
13F
|
Company |
2.1%
|
4,133,277
|
$146,152,675 | — | 31 Mar 2025 | |
| Third Rock Ventures III, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,104,130
|
$137,811,510 | — | 08 Jun 2022 | |
| Woodline Partners LP |
13F
|
Company |
2%
|
3,887,036
|
$137,445,593 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.9%
|
3,702,909
|
$130,934,875 | — | 31 Mar 2025 | |
| Casdin Capital, LLC |
13F
|
Company |
1.9%
|
3,697,933
|
$130,758,911 | — | 31 Mar 2025 | |
| Holocene Advisors, LP |
13F
|
Company |
1.9%
|
3,691,744
|
$130,540,068 | — | 31 Mar 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.7%
|
3,317,332
|
$117,300,860 | — | 31 Mar 2025 | |
| a16z Capital Management, L.L.C. |
13F
|
Company |
1.4%
|
2,748,523
|
$97,187,773 | — | 31 Mar 2025 | |
| Alexis Borisy |
3/4/5
|
Director |
—
mixed-class rows
|
2,350,458
mixed-class rows
|
$92,479,473 | — | 26 Jun 2025 | |
| Lunate Capital Ltd |
13F
|
Company |
1.1%
|
2,196,200
|
$77,657,632 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
2,164,501
|
$76,536,756 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1%
|
1,930,468
|
$68,261,348 | — | 31 Mar 2025 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.89%
|
1,717,048
|
$60,714,817 | — | 31 Mar 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
0.87%
|
1,673,429
|
$59,173,000 | — | 31 Mar 2025 | |
| Logos Global Management LP |
13F
|
Company |
0.83%
|
1,600,000
|
$56,576,000 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.8%
|
1,534,757
|
$54,269,007 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.77%
|
1,490,658
|
$52,709,667 | — | 31 Mar 2025 | |
| Boxer Capital Management, LLC |
13F
|
Company |
0.68%
|
1,317,977
|
$46,603,667 | — | 31 Mar 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.66%
|
1,281,640
|
$45,318,790 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.65%
|
1,255,687
|
$44,401,113 | — | 31 Mar 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.55%
|
1,064,046
|
$37,624,667 | — | 31 Mar 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.52%
|
997,455
|
$35,270,009 | — | 31 Mar 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.39%
|
750,665
|
$26,543,514 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.39%
|
747,560
|
$26,436,876 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.38%
|
741,860
|
$26,232,194 | — | 31 Mar 2025 | |
| Finepoint Capital LP |
13F
|
Company |
0.36%
|
691,260
|
$24,442,954 | — | 31 Mar 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.34%
|
656,176
|
$23,202,383 | — | 31 Mar 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.34%
|
655,134
|
$23,165,668 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.32%
|
609,388
|
$21,547,960 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.3%
|
582,721
|
$20,605,029 | — | 31 Mar 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.29%
|
563,755
|
$19,934,377 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.27%
|
524,428
|
$18,543,774 | — | 31 Mar 2025 | |
| MIC Capital Management UK LLP |
13F
|
Company |
0.26%
|
508,569
|
$17,983,000 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.25%
|
482,107
|
$17,047,304 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.25%
|
477,860
|
$16,897,129 | — | 31 Mar 2025 |
Institutional Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q2 2025
As of 30 Jun 2025,
Revolution Medicines, Inc. - Common Stock (RVMD) was held by
305 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
190,726,235 shares.
The largest 10 holders included
VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, BAKER BROS. ADVISORS LP, BlackRock, Inc., FMR LLC, Nextech Invest, Ltd., Paradigm Biocapital Advisors LP, and BVF INC/IL.
This page lists
307
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
281
Q2 2025 holders
305
Holder diff
24
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.